Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Nature
|
March 25, 2022
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature
|
December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature
|
July 12, 2018
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L Roth, Cristina Puig-Saus, Ruby Yu, et al.
Cell
|
July 10, 2020
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Mehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.
Nature Biotechnology
|
August 29, 2020
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Jeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Test performance evaluation of SARS-CoV-2 serological assays
Jeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Nature
|
May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Science (New York, N.Y.)
|
October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
David E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Nature
|
March 25, 2022
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature
|
December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2
Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature
|
July 12, 2018
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L Roth, Cristina Puig-Saus, Ruby Yu, et al.
Cell
|
July 10, 2020
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Mehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.
Nature Biotechnology
|
August 29, 2020
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Jeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Test performance evaluation of SARS-CoV-2 serological assays
Jeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Nature
|
May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Science (New York, N.Y.)
|
October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
David E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Page
of 3